These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3928163)

  • 1. [The effect of auranofin on lymphocyte functions in vitro].
    Strejcek J; Jíra M; Horký J
    Cas Lek Cesk; 1985 Aug; 124(33):1045-7. PubMed ID: 3928163
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of a new antirheumatic drug, triethylphosphine gold (auranofin), on in vitro lymphocyte and monocyte cytotoxicity.
    Russell AS; Davis P; Miller C
    J Rheumatol; 1982; 9(1):30-5. PubMed ID: 6806471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro boost of human NK activity by a triethylphosphine gold derivative.
    Russell AS; Nakashima S; Miller C
    Clin Exp Immunol; 1984 Jul; 57(1):207-10. PubMed ID: 6204799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auranofin effects on cytotoxicity.
    Lorber A
    J Rheumatol; 1983 Jun; 10(3):517. PubMed ID: 6411923
    [No Abstract]   [Full Text] [Related]  

  • 5. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E
    Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of macrophage-lymphocyte interactions by the antiarthritic gold compound, auranofin.
    Griswold DE; Lee JC; Poste G; Hanna N
    J Rheumatol; 1985 Jun; 12(3):490-7. PubMed ID: 2931519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of lymphocyte subpopulations using monoclonal antibodies in patients with rheumatoid arthritis undergoing treatment with a new gold salt (auranofin)].
    Di Matteo L; D'Incecco V; Evangelista L; Castiglione C; Consoli G
    Boll Soc Ital Biol Sper; 1985 May; 61(5):777-81. PubMed ID: 3927943
    [No Abstract]   [Full Text] [Related]  

  • 9. Auranofin.
    Davis P
    Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
    Wessel J; Davis P
    J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
    [No Abstract]   [Full Text] [Related]  

  • 11. [Distribution of gold from aurothiomalate and gold trielthylphosphine in whole blood, lymphocytes and lymphocyte chromatin of patients with chronic polyarthritis].
    Teherani DK; Altmann H; Tausch G; Eberl R
    Wien Klin Wochenschr Suppl; 1984; 156():53-5. PubMed ID: 6442060
    [No Abstract]   [Full Text] [Related]  

  • 12. [Auranofin (Ridaura). A peroral gold salt].
    Manthorpe R
    Ugeskr Laeger; 1985 Mar; 147(10):888-90. PubMed ID: 3920800
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of auranofin and sodium aurothiomalate on peripheral blood monocytes.
    Scheinberg MA; Santos LM; Finkelstein AE
    J Rheumatol; 1982; 9(3):366-9. PubMed ID: 6288942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of rheumatoid arthritis with the oral gold preparation Auranofin].
    Trnavský K; Zbojanová M
    Cas Lek Cesk; 1982 Nov; 122(45):1382-4. PubMed ID: 6821244
    [No Abstract]   [Full Text] [Related]  

  • 15. [Generation of human peripheral blood suppressor cell activity by auranofin].
    Kobayashi K; Sato H; Sekine F; Ohno I; Ohseto Y; Hamai T; Negishi M; Takahashi T
    Arerugi; 1982 Sep; 31(9):948-55. PubMed ID: 6217798
    [No Abstract]   [Full Text] [Related]  

  • 16. The augmentation of human NK-cell activity by auranofin compared to interferon.
    Russell AS; Miller C
    Int J Immunopharmacol; 1984; 6(5):451-4. PubMed ID: 6209229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in mononuclear cell function in patients with rheumatoid arthritis following treatment with auranofin.
    Coughlan RJ; Richter MB; Panayi GS
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():25-32. PubMed ID: 6432410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.
    Wolach B; DeBoard JE; Coates TD; Baehner RL; Boxer LA
    J Lab Clin Med; 1982 Jul; 100(1):37-44. PubMed ID: 6283001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Therapeutic innovation in rheumatoid arthritis: worldwide auranofin symposium. Montreal, October 20-21, 1981.
    J Rheumatol Suppl; 1982; 8():1-209. PubMed ID: 6813471
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of auranofin on DNA and protein synthesis in human lymphocytes.
    Finkelstein AE; Burrone OR; Walz DT; Misher A
    J Rheumatol; 1977; 4(3):245-51. PubMed ID: 336886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.